Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress inpatients with type 2 diabetes mellitus
Aaron S. Kelly, Andrea M. Thelen, Daniel R. Kaiser, J. Michael Gonzalez-Campoy, Alan J. Bank
Dive into the research topics of 'Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress inpatients with type 2 diabetes mellitus'. Together they form a unique fingerprint.